What is it about?
He here describe a very sensitive technique for BRAF testing in melanoma.
Featured Image
Why is it important?
This is of great importance given the fact that these BRAF V600- results have a direct impact on the choice of treatment (and therefore survival) in metastatic melanoma patients. Furthermore, rare genetic alterations such as BRAF fusions can respond to sorafenib.
Read the Original
This page is a summary of: Hybrid Capture‐Based Genomic Profiling Identifies BRAF V600 and Non‐V600 Alterations in Melanoma Samples Negative by Prior Testing, The Oncologist, January 2019, Alphamed Press,
DOI: 10.1634/theoncologist.2018-0271.
You can read the full text:
Contributors
The following have contributed to this page
